Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare

International Journal of Mental Health Systems

Volumn 7, Issue 1, 2013, Pages

  Ostuzzi, Giovanni ^a   Bighelli, Irene ^a   Carrara, Barbara Vanessa ^b   Dusi, Nicola ^a   Imperadore, Giuseppe ^b   Lintas, Camilla ^c   Nifosì, Francesco ^b   Nosè, Michela ^a   Piazza, Carlo ^d   Purgato, Marianna ^a   Rizzo, Raffaella ^b   Barbui, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Unit of Psychiatry II   (Italy)

^c Unit of Psychiatry I   (Italy)

^d Unit of Psychiatry IV   (Italy)

Author keywords

Knowledge transfer; Mental healthcare; Psychotropic drugs; Treatment guidelines

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GRADING OF RECOMMENDATION ASSESSMENT, DEVELOPMENT AND EVALUATION; HUMAN; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIST;

EID: 84876854920     PISSN: None     EISSN: 17524458     Source Type: Journal    
DOI: 10.1186/1752-4458-7-14     Document Type: Article

References (29)

1. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 1999, 318:527-530. 10.1136/bmj.318.7182.527, 1114973, 10024268.
2. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation of research findings. Implement Sci 2012, 7:50. 10.1186/1748-5908-7-50, 3462671, 22651257.
3. Guyatt GH, Oxman AD, Schunemann HJ. GRADE guidelines-an introduction to the 10th-13th articles in the series. J Clin Epidemiol 2013, 66:121-123. 10.1016/j.jclinepi.2012.05.011, 22968177.
4. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, Liberati A. Going from evidence to recommendations. BMJ 2008, 336:1049-1051. 10.1136/bmj.39493.646875.AE, 2376019, 18467413.
5. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008, 336:995-998. 10.1136/bmj.39490.551019.BE, 2364804, 18456631.
6. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Onso-Coello P. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. 10.1136/bmj.39489.470347.AD, 2335261, 18436948.
7. Barbui C, Cipriani A. What are evidence-based treatment recommendations?. Epidemiol Psychiatr Sci 2011, 20:29-31. 10.1017/S2045796011000084, 21657112.
8. Dua T, Barbui C, Clark N, Fleischmann A, Poznyak V, van OM. Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations. PLoS Med 2011, 8:e1001122. 10.1371/journal.pmed.1001122, 3217030, 22110406.
9. Tansella M, Amaddeo F, Burti L, Lasalvia A, Ruggeri M. Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatr Scand Suppl 2006, 113:90-94.
10. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011, 64:383-394. 10.1016/j.jclinepi.2010.04.026, 21195583.
11. Barbui C, Dua T, Van Ommeren M, Yasamy M, Fleischmann A, Clark N. Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders. PLoS Med 2010, 7:e1000322. 10.1371/journal.pmed.1000322, 2930877, 20824176.
12. Blozik E, Nothacker M, Bunk T, Szecsenyi J, Ollenschlager G, Scherer M. Simultaneous development of guidelines and quality indicators - how do guideline groups act? A worldwide survey. Int J Health Care Qual Assur 2012, 25:712-729. 10.1108/09526861211270659, 23276064.
13. Kotter T, Blozik E, Scherer M. Methods for the guideline-based development of quality indicators-a systematic review. Implement Sci 2012, 7:21. 10.1186/1748-5908-7-21, 3368783, 22436067.
14. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S. Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490. 428525, 15205295.
15. Eccles MP, Grimshaw JM, Shekelle P, Schunemann HJ, Woolf S. Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implement Sci 2012, 7:60. 10.1186/1748-5908-7-60, 3523009, 22762776.
16. Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y. GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013, in press.
17. Barrett B. Evidence, values, guidelines and rational decision-making. J Gen Intern Med 2012, 27:238-240. 10.1007/s11606-011-1903-6, 3270230, 21971602.
18. Purgato M, Barbui C. Dichotomizing rating scale scores in psychiatry: a bad idea?. Epidemiol Psychiatr Sci 2012, in press.
19. Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J. Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting. Pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus promethazine. Br J Psychiatry 2004, 185:63-69. 10.1192/bjp.185.1.63, 15231557.
20. Huf G, Coutinho ES, Adams CE. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomised controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promethazine. BMJ 2007, 335:869. 10.1136/bmj.39339.448819.AE, 2043463, 17954515.
21. Huf G, Coutinho ES, Ferreira MA, Ferreira S, Mello F, Adams CE. TREC-SAVE: a randomised trial comparing mechanical restraints with use of seclusion for aggressive or violent seriously mentally ill people: study protocol for a randomised controlled trial. Trials 2011, 12:180. 10.1186/1745-6215-12-180, 3154155, 21774823.
22. Barbui C, Tansella M. Guideline implementation in mental health: current status and future goals. Epidemiol Psychiatr Sci 2012, 21:227-229. 10.1017/S2045796012000200, 22793175.
23. Hayward RS, Guyatt GH, Moore KA, McKibbon KA, Carter AO. Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ 1997, 156:1715-1723. 1227586, 9220923.
24. Parmelli E, Flodgren G, Beyer F, Baillie N, Schaafsma ME, Eccles MP. The effectiveness of strategies to change organisational culture to improve healthcare performance: a systematic review. Implement Sci 2011, 6:33. 10.1186/1748-5908-6-33, 3080823, 21457579.
25. Gagliardi AR, Brouwers MC, Bhattacharyya OK. The guideline implementability research and application network (GIRAnet): an international collaborative to support knowledge exchange: study protocol. Implement Sci 2012, 7:26. 10.1186/1748-5908-7-26, 3338081, 22471937.
26. Gagliardi AR. Translating knowledge to practice: optimizing the use of guidelines. Epidemiol Psychiatr Sci 2012, 21:231-236. 10.1017/S2045796012000212, 22793367.
27. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004, 8:iii-72.
28. Weinmann S, Koesters M, Becker T. Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review. Acta Psychiatr Scand 2007, 115:420-433. 10.1111/j.1600-0447.2007.01016.x, 17498153.
29. Ransohoff DF, Pignone M, Sox HC. How to decide whether a clinical practice guideline is trustworthy. JAMA 2013, 309:139-140. 10.1001/jama.2012.156703, 23299601.